drugset / Trial / NCT02209454

Comparative Bioavailability of Dexketoprofen Trometamol Oral Solution vs Tablet Formulations

NCT02209454

Phase 1 Completed 26 enrolled Menarini Group Simbec Research · collab
RandomizedCrossoverOpen-label

Summary

The purpose of this study is to compare the bioavailability of 25 mg DKP.TRIS given as an Enantyum® oral solution (Test formulation) and Keral® tablet (Reference formulation). In addition, this study intends to evaluate the safety and tolerability of Test and Reference formulations.

Timeline

Start
2014-04
Primary completion
2014-05
Completion
2014-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexketoprofen Trometamol Small molecule 25 mg Oral

Indications

No indication recorded.